Biggest changeThe following tables summarize our loans held for investment as of December 31, 2024 and 2023: As of December 31, 2024 Outstanding Principal Original Issue Discount Carrying Value Weighted Average Remaining Life (Years) (1) Senior Term Loans $ 404,721,554 $ (2,244,508 ) $ 402,477,046 2.2 Current expected credit loss reserve - - (4,346,869 ) Total loans held at carrying value, net $ 404,721,554 $ (2,244,508 ) $ 398,130,177 As of December 31, 2023 Outstanding Principal Original Issue Discount Carrying Value Weighted Average Remaining Life (Years) (1) Senior Term Loans $ 355,745,305 $ (2,104,695 ) $ 353,640,610 2.1 Current expected credit loss reserve - - (4,972,647 ) Total loans held at carrying value, net $ 355,745,305 $ (2,104,695 ) $ 348,667,963 (1) Weighted average remaining life is calculated on the carrying value of the loans as of December 31, 2024 and 2023, respectively. 73 The following tables present changes in loans held for investment at carrying value as of and for the years ended December 31, 2024 and 2023: Principal Original Issue Discount Current Expected Credit Loss Reserve Carrying Value Balance at December 31, 2023 $ 355,745,305 $ (2,104,695 ) $ (4,972,647 ) $ 348,667,963 New fundings 161,289,523 (1,836,952 ) - 159,452,571 Principal repayment of loans (102,461,111 ) - - (102,461,111 ) Accretion of original issue discount - 1,697,139 - 1,697,139 Transfer of loan held for investment to loan held for sale (19,000,000 ) 213,913 (18,786,087 ) PIK Interest 9,147,837 - - 9,147,837 Decrease in provision for current expected credit losses - - 411,865 411,865 Balance at December 31, 2024 $ 404,721,554 $ (2,244,508 ) $ (4,346,869 ) $ 398,130,177 Principal Original Issue Discount Current Expected Credit Loss Reserve Carrying Value Balance at December 31, 2022 $ 343,029,334 $ (3,755,796 ) $ (3,940,939 ) $ 335,332,599 New fundings 93,533,516 (1,332,340 ) - 92,201,176 Principal repayment of loans (76,876,048 ) - - (76,876,048 ) Accretion of original issue discount - 2,983,441 - 2,983,441 Transfer of loan held for investment to loan held for sale (13,399,712 ) - - (13,399,712 ) PIK Interest 9,458,215 - - 9,458,215 Increase in provision for current expected credit losses - - (1,031,708 ) (1,031,708 ) Balance at December 31, 2023 $ 355,745,305 $ (2,104,695 ) $ (4,972,647 ) $ 348,667,963 We may make modifications to loans, including loans that are in default.
Biggest changeAs of December 31, 2025 and 2024, our portfolio had the following interest rate floors: 70 As of December 31, 2025 As of December 31, 2024 Rate Floor Outstanding Principal Weighted Average Cash Coupon Percentage of Portfolio Outstanding Principal Weighted Average Cash Coupon Percentage of Portfolio 8.50% $ 44,642,571 13.3 % 10.9 % $ 51,068,629 13.6 % 12.6 % 8.00% 1,380,000 15.5 % 0.3 % 7,620,000 14.7 % 1.9 % 7.75% - 0.0 % 0.0 % 16,880,308 18.1 % 4.2 % 7.50% 62,121,045 14.1 % 15.1 % 42,839,358 14.4 % 10.6 % 7.00% 89,852,341 10.7 % 21.9 % 75,902,295 11.1 % 18.8 % 6.25% 15,771,067 13.3 % 3.8 % 19,324,557 14.0 % 4.8 % 5.50% - 0.0 % 0.0 % 580,000 18.0 % 0.1 % 4.00% 20,427,778 12.5 % 5.0 % - 0.0 % 0.0 % 3.72% 5,000,000 14.0 % 1.2 % - 0.0 % 0.0 % 3.25% - 0.0 % 0.0 % 18,966,668 27.1 % 4.7 % 0.00% 17,200,000 13.3 % 4.2 % 17,400,000 14.0 % 4.3 % Fixed-rate 154,680,286 11.9 % 37.6 % 154,139,739 12.4 % 38.1 % $ 411,075,088 12.3 % 100.0 % $ 404,721,554 13.6 % 100.0 % The following tables present changes in loans held for investment at carrying value as of and for the years ended December 31, 2025 and 2024: Principal Original Issue Discount Current Expected Credit Loss Reserve Carrying Value Balance at December 31, 2024 $ 404,721,554 $ (2,244,508 ) $ (4,346,869 ) $ 398,130,177 Purchase of investments 79,412,079 (2,062,541 ) - 77,349,538 Principal repayment of loans (79,221,108 ) - - (79,221,108 ) Accretion of original issue discount - 2,187,528 - 2,187,528 Capitalized PIK Interest 6,162,563 - - 6,162,563 Increase in provision for current expected credit losses - - (715,916 ) (715,916 ) Balance at December 31, 2025 $ 411,075,088 $ (2,119,521 ) $ (5,062,785 ) $ 403,892,782 Principal Original Issue Discount Current Expected Credit Loss Reserve Carrying Value Balance at December 31, 2023 $ 355,745,305 $ (2,104,695 ) $ (4,972,647 ) $ 348,667,963 Purchase of investments 161,289,523 (1,836,952 ) - 159,452,571 Principal repayment of loans (102,461,111 ) - - (102,461,111 ) Accretion of original issue discount - 1,697,139 - 1,697,139 Transfer of loan held for investment to loan held for sale (19,000,000 ) 213,913 (18,786,087 ) Capitalized PIK Interest 9,147,837 - - 9,147,837 Increase in provision for current expected credit losses - - 411,865 411,865 Balance at December 31, 2024 $ 404,721,554 $ (2,244,508 ) $ (4,346,869 ) $ 398,130,177 Portfolio Asset Quality Our Manager uses an ongoing investment risk rating system to characterize and monitor our outstanding loans.
Based on a 5-point scale, our loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: Rating Definition 1 Very low risk 2 Low risk 3 Moderate/average risk 4 High risk/potential for loss: a loan that has a risk of realizing a principal loss 5 Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded The risk ratings are primarily determined based on current and historical performance metrics specific to each portfolio company, as well as consideration of future economic conditions and each borrower’s estimated ability to meet debt service requirements.
Based on a 5-point scale, our loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: 71 Rating Definition 1 Very low risk 2 Low risk 3 Moderate/average risk 4 High risk/potential for loss: a loan that has a risk of realizing a principal loss 5 Impaired/loss likely: a loan that has a high risk of realizing principal loss, has incurred principal loss or an impairment has been recorded The risk ratings are primarily determined based on current and historical performance metrics specific to each portfolio company, as well as consideration of future economic conditions and each borrower’s estimated ability to meet debt service requirements.
Additionally, we had cash inflows related to draw downs on our Revolving Loan of $159.0 million, and inflows related to proceeds from notes payable of $50.0 million, which were offset by approximately $170.0 million in repayments on our Revolving Loan, approximately $41.6 million in dividends paid, approximately $1.1 million in debt issuance costs paid, and approximately $1.2 million in offering costs paid associated with the ATM offering.
Additionally, we had cash inflows related to draw downs on our Revolving Loan of $159.0 million, and inflows related to proceeds from notes payable of $50.0 million, which were offset by approximately $170.0 81 million in repayments on our Revolving Loan, approximately $41.6 million in dividends paid, approximately $1.1 million in debt issuance costs paid, and approximately $1.2 million in offering costs paid associated with the ATM offering.
Additionally, the Company must comply with certain financial and non-financial covenants including but not limited to: (1) minimum stockholders' equity of $200.0 million, (2) maximum aggregate indebtedness of $225.0 million, subject to increase from time to time based upon ratable increases in stockholders' equity, and (3) maintenance of a credit rating.
Additionally, the Company must comply with certain financial and non-financial covenants including but not limited to: (1) minimum stockholders' equity of $200.0 million, (2) 80 maximum aggregate indebtedness of $225.0 million, subject to increase from time to time based upon ratable increases in stockholders' equity, and (3) maintenance of a credit rating.
Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of our loan portfolio, and (iv) our current and future view of the macroeconomic environment.
Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect 83 the risk characteristics of our loan portfolio, and (iv) our current and future view of the macroeconomic environment.
We bear all other costs and expenses of our operations and transactions, including (without limitation) fees and expenses relating to: • organizational and offering expenses; • quarterly valuation expenses; • fees payable to third parties relating to, or associated with, making loans and valuing loans (including third-party valuation firms); • fees and expenses associated with investor relations and marketing efforts (including attendance at investment conferences and similar events); • accounting and loan servicing fees from our third-party fund administrator; • audit and tax compliance fees and expenses from our independent registered public accounting firm; • federal and state registration fees; • any exchange listing fees; • federal, state and local taxes; • independent directors’ fees and expenses; 64 • brokerage commissions; • costs of proxy statements, stockholders’ reports and notices; and • costs of preparing government filings, including periodic and current reports with the SEC.
We bear all other costs and expenses of our operations and transactions, including (without limitation) fees and expenses relating to: • organizational and offering expenses; • quarterly valuation expenses; • fees payable to third parties relating to, or associated with, making loans and valuing loans (including third-party valuation firms); • fees and expenses associated with investor relations and marketing efforts (including attendance at investment conferences and similar events); • accounting and loan servicing fees from our third-party fund administrator; • audit and tax compliance fees and expenses from our independent registered public accounting firm; • federal and state registration fees; • any exchange listing fees; • federal, state and local taxes; • independent directors’ fees and expenses; 68 • brokerage commissions; • costs of proxy statements, stockholders’ reports and notices; and • costs of preparing government filings, including periodic and current reports with the SEC.
Leverage Policies 77 Although we are not required to maintain any particular leverage ratio, we expect to employ prudent amounts of leverage and, when appropriate, to use debt as a means of providing additional funds for the acquisition of loans, to refinance existing debt or for general corporate purposes.
Leverage Policies Although we are not required to maintain any particular leverage ratio, we expect to employ prudent amounts of leverage and, when appropriate, to use debt as a means of providing additional funds for the acquisition of loans, to refinance existing debt or for general corporate purposes.
The following discussion addresses the accounting estimates that we believe apply to us based on the nature of our operations. Our most critical accounting estimates involve a significant level of estimation 78 uncertainty that have had or are reasonably likely to have a material impact on our financial conditions and results of operations.
The following discussion addresses the accounting estimates that we believe apply to us based on the nature of our operations. Our most critical accounting estimates involve a significant level of estimation uncertainty that have had or are reasonably likely to have a material impact on our financial conditions and results of operations.
Distributable Earnings is one of many factors considered by our Board in authorizing dividends and, while not a direct measure of net taxable income, over time, the measure can be considered a useful indicator of our dividends. 74 Distributable Earnings should not be considered as substitutes for GAAP net income.
Distributable Earnings is one of many factors considered by our Board in authorizing dividends and, while not a direct measure of net taxable income, over time, the measure can be considered a useful indicator of our dividends. Distributable Earnings should not be considered as substitutes for GAAP net income.
These estimates may change in 79 future periods based on available future macro-economic data and might result in a material change in the Company’s future estimates of expected credit losses for its loan portfolio.
These estimates may change in future periods based on available future macro-economic data and might result in a material change in the Company’s future estimates of expected credit losses for its loan portfolio.
Additionally, the Company must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1, and (3) maintaining a leverage ratio less than 1.50 to 1. As of December 31, 2024, the Company is in compliance with all financial covenants with respect to the Revolving Loan.
Additionally, the Company must comply with certain financial covenants including: (1) maximum capital expenditures of $150,000, (2) maintaining a debt service coverage ratio greater than 1.35 to 1, and (3) maintaining a leverage ratio less than 1.50 to 1. As of December 31, 2025, the Company is in compliance with all financial covenants with respect to the Revolving Loan.
Our Shelf Registration Statement on Form S-3 became effective on January 19, 2023, allowing us to sell, from time to time in one or more offerings, up to $500 million of our securities, including common stock, preferred stock, debt securities, warrants and rights (including as part of a unit) to purchase shares of our common stock, preferred stock, or debt securities.
Our Shelf Registration Statement on Form S-3 became effective on January 19, 2023 (the "Previous Registration Statement"), allowing us to sell, from time to time in one or more offerings, up to $500 million of our securities, including common stock, preferred stock, debt securities, warrants and rights (including as part of a unit) to purchase shares of our common stock, preferred stock, or debt securities.
ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have analyzed our various federal and state filing positions and believe that our income tax filing positions and deductions are documented and supported as of December 31, 2024 and 2023.
ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. We have analyzed our various federal and state filing positions and believe that our income tax filing positions and deductions are documented and supported as of December 31, 2025 and 2024.
The risk ratings shown in the following table as of December 31, 2024 and 2023 consider borrower specific credit history and performance and reflect a quarterly re-evaluation of overall current macroeconomic conditions affecting the Company’s borrowers, specifically those designated as held for investment.
The risk ratings shown in the following table as of December 31, 2025 and 2024 consider borrower specific credit history and performance and reflect a quarterly re-evaluation of overall current macroeconomic conditions affecting the Company’s borrowers, specifically those designated as held for investment.
The Manager utilizes a third-party valuation appraiser to assist with the Company’s valuation process primarily using comparable transactions to estimate enterprise value of its portfolio companies and supplement such analysis with a multiple-based approach to enterprise value to revenue multiples of publicly-traded comparable companies obtained from Bloomberg and S&P Capital IQ as of December 31, 2024, to which the Manager may apply a private company discount based on the Company’s current borrower profile.
The Manager utilizes a third-party valuation appraiser to assist with the Company’s valuation process primarily using comparable transactions to estimate enterprise value of its portfolio companies and supplement such analysis with a multiple-based approach to enterprise value to revenue multiples of publicly-traded comparable companies obtained from sources such as Bloomberg and/or S&P Capital IQ as of December 31, 2025, to which the Manager may apply a private company discount based on the Company’s current borrower profile.
Excise tax expense, if any, is included in the line item, income tax expense. For the years ended December 31, 2024 and 2023, we did not incur excise tax expense.
Excise tax expense, if any, is included in the line item, income tax expense. For the years ended December 31, 2025 and 2024, we did not incur excise tax expense.
Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/28/2024 4/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/28/2024 7/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2024 10/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2024 1/13/2025 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/31/2024 1/13/2025 $ 0.18 $ 0.18 $ - $ 0.18 Total cash dividend $ 2.06 $ 2.06 - $ 2.06 Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/31/2023 4/14/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/30/2023 7/14/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/29/2023 10/13/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/29/2023 1/12/2024 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/29/2023 1/12/2024 $ 0.29 $ 0.29 $ - $ 0.29 Total cash dividend $ 2.17 $ 2.17 $ - $ 2.17 Critical Accounting Estimates Our consolidated financial statements are prepared in accordance with GAAP which requires the use of estimates and assumptions that involve the exercise of judgment as to future uncertainties.
Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/31/2025 4/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/30/2025 7/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2025 10/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2025 1/15/2026 $ 0.47 $ 0.47 $ - $ 0.47 Total cash dividend $ 1.88 $ 1.88 - $ 1.88 Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/28/2024 4/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/28/2024 7/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2024 10/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2024 1/13/2025 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/31/2024 1/13/2025 $ 0.18 $ 0.18 $ - $ 0.18 Total cash dividend $ 2.06 $ 2.06 $ - $ 2.06 Critical Accounting Estimates Our consolidated financial statements are prepared in accordance with GAAP which requires the use of estimates and assumptions that involve the exercise of judgment as to future uncertainties.
Incentive fees decreased approximately $0.8 million primarily attributable to the year over year decrease in Core Earnings, as defined in the Management Agreement, of $2.4 million, the base on which the incentive fees are earned. • General and administrative expense increased by approximately $0.1 million and professional fees decreased by approximately $0.3 million for the year ended December 31, 2024 compared to the year ended December 31, 2023.
Incentive fees decreased approximately $0.2 million primarily attributable to the year over year decrease in Core Earnings, as defined in the Management Agreement, of $0.8 million, the base on which the incentive fees are earned. • General and administrative expense decreased by approximately $0.1 million and professional fees increased by approximately $0.1 million for the year ended December 31, 2025 compared to the year ended December 31, 2024.
Inc. (each a “Sales Agent” and together the “Sales Agents”) under which the Company may, from time to time, offer and sell shares of common stock, having an aggregate offering price of up to $75.0 million.
(each a “Sales Agent” and together the “Previous Sales Agents”) under which the Company may, from time to time, offer and sell shares of common stock, having an aggregate offering price of up to $75.0 million.
Dividends Declared Per Share The following tables summarize the Company’s dividends declared during the years ended December 31, 2024 and 2023: Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/28/2024 4/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/28/2024 7/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2024 10/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2024 1/13/2025 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/31/2024 1/13/2025 $ 0.18 $ 0.18 $ - $ 0.18 Total cash dividend $ 2.06 $ 2.06 - $ 2.06 Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/31/2023 4/14/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/30/2023 7/14/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/29/2023 10/13/2023 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/29/2023 1/12/2024 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/29/2023 1/12/2024 $ 0.29 $ 0.29 $ - $ 0.29 Total cash dividend $ 2.17 $ 2.17 $ - $ 2.17 The payment of these dividends is not indicative of our ability to pay such dividends in the future.
Dividends Declared Per Share The following tables summarize the Company’s dividends declared during the years ended December 31, 2025 and 2024: 75 Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/31/2025 4/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/30/2025 7/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2025 10/15/2025 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2025 1/15/2026 $ 0.47 $ 0.47 $ - $ 0.47 Total cash dividend $ 1.88 $ 1.88 - $ 1.88 Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/28/2024 4/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 6/28/2024 7/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 9/30/2024 10/15/2024 $ 0.47 $ 0.47 $ - $ 0.47 Regular cash dividend 12/31/2024 1/13/2025 $ 0.47 $ 0.47 $ - $ 0.47 Special cash dividend 12/31/2024 1/13/2025 $ 0.18 $ 0.18 $ - $ 0.18 Total cash dividend $ 2.06 $ 2.06 $ - $ 2.06 The payment of these dividends is not indicative of our ability to pay such dividends in the future.
Under the terms of the Sales Agreement, the Company has agreed to pay the Sales Agents a commission of up to 3.0% of the gross proceeds from each sale of common stock sold through the Sales Agents.
Under the terms of the Previous Sales Agreement, the Company agreed to pay the Previous Sales Agents a commission of up to 3.0% of the gross proceeds from each sale of common 79 stock sold through the Previous Sales Agents.
Additionally, we recognized approximately $3.2 million of interest income from prepayment fees and acceleration of original issue discounts and other upfront fees during the year ended December 31, 2024, as compared to $3.5 million for the year ended December 31, 2023, contributing to $0.3 million of the decline.
Additionally, we recognized approximately $5.2 million of interest income from prepayment fees and acceleration of original issue discounts and other upfront fees during the year ended December 31, 2025, as compared to $3.2 million for the year ended December 31, 2024.
Recent Accounting Pronouncements Refer to footnote 2 to our consolidated financial statements for the year ended December 31, 2024, titled “ Significant Accounting Policies ” for information on recent accounting pronouncements. 82
Recent Accounting Pronouncements Refer to footnote 2 to our consolidated financial statements for the year ended December 31, 2025, titled “ Significant Accounting Policies ” for information on recent accounting pronouncements. 85
Interest on our loans is generally payable monthly. The principal amount of our loans and any accrued but unpaid interest thereon generally become due at the applicable maturity date. In some cases, our interest income includes a paid-in-kind (“PIK”) component for a portion of the total interest.
Revenues We generate revenue primarily in the form of interest income on loans which is generally payable monthly. The principal amount of our loans and any accrued but unpaid interest thereon generally become due at the applicable maturity date. In some cases, our interest income includes a paid-in-kind (“PIK”) component for a portion of the total interest.
Net Cash Provided/(Used in) by Financing Activities For the years ended December 31, 2024 and 2023, we reported “Net cash provided by/(used in) financing activities” of $34.6 million and $(24.3) million, respectively. For the year ended December 31, 2024, cash inflows of approximately $39.6 million related to proceeds received from sales of our common stock through the ATM offering.
Net Cash Provided/(Used in) by Financing Activities For the years ended December 31, 2025 and 2024, we reported “Net cash (used in)/provided by financing activities” of $(49.0) million and $34.6 million, respectively. For the year ended December 31, 2025, cash inflows of approximately $1.0 million related to proceeds received from sales of our common stock through the ATM offering.
Subsequent Updates to Our Loan Portfolio in 2025 During the period from January 1, 2025 through March 12, 2025, we advanced approximately $1.1 million of principal to existing borrowers under delayed draw term loan facilities.
Subsequent Updates to Our Loan Portfolio in 2026 During the period from January 1, 2026 through March 12, 2026, we advanced approximately $51.1 million of principal to existing borrowers under delayed draw and revolving loan facilities.
As of December 31, 2024 and 2023, all of our cash was unrestricted and totaled approximately $26.4 million and $7.9 million, respectively.
As of December 31, 2025 and 2024, all of our cash was unrestricted and totaled approximately $14.9 million and $26.4 million, respectively.
To the extent that our cash available for distribution is less than the amount required to be distributed under the REIT provisions of the Code, we may be required to fund distributions from working capital or through equity, equity-related or debt financings or, in certain circumstances, asset sales, as to which our ability to consummate transactions in a timely manner on favorable terms, or at all, cannot be assured, or we may make a portion of the Required Distribution in the form of a taxable stock distribution or distribution of debt securities.
To the extent that our cash available for distribution is less than the amount required to be distributed under the REIT provisions of the Code, we may be required to fund distributions from working capital or through equity, equity-related or debt financings or, in certain circumstances, asset sales, as to which our ability to consummate transactions in a timely manner on favorable terms, or at all, cannot be assured, or we may make a portion of the Required Distribution in the form of a taxable stock distribution or distribution of debt securities. 82 The following table summarizes the Company’s dividends declared during the years ended December 31, 2025 and 2024.
During the years ended December 31, 2024 and 2023, the Company sold an aggregate of 2,489,290 and 79,862 shares of the Company’s common stock under the Sales Agreement, respectively, which generated which generated proceeds, net of commissions and offering expenses of approximately $38.4 million and $1.2 million, during the comparable periods.
During the years ended December 31, 2025 and 2024, the Company sold an aggregate of 64,557 and 2,489,290 shares of the Company’s common stock under the Sales Agreements, respectively, which generated which generated proceeds, net of commissions and offering expenses of approximately $0.9 million and $38.4 million, during the comparable periods.
The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1.
The applicable margin is derived from a floating rate grid based upon the ratio of debt to equity of CAL and increases from 0% at a ratio of 0.25 to 1 to 1.25% at a ratio of 1.5 to 1. The Revolving Loan has a maturity date of June 30, 2028.
The Revolving Loan has a maturity date of June 30, 2026. 75 The Revolving Loan provides for certain affirmative covenants, including requiring us to deliver financial information and any notices of default, and conducting business in the normal course.
The Revolving Loan provides for certain affirmative covenants, including requiring us to deliver financial information and any notices of default, and conducting business in the normal course.
For the year ended December 31, 2024, we had net repayments of $11.0 million against the Revolving Loan. As of December 31, 2024, we had $55.0 million available and $55.0 million outstanding under the Revolving Loan. Refer to Note 8 of the consolidated financial statements for additional information.
For the year ended December 31, 2025, we had net repayments of $5.9 million against the Revolving Loan. As of December 31, 2025, we had $60.9 million available and $49.1 million outstanding under the Revolving Loan. Refer to Note 8 of the consolidated financial statements for additional information.
Non-GAAP Measures and Key Financial Measures and Indicators As a commercial mortgage real estate investment trust, we believe the key financial measures and indicators for our business are Distributable Earnings, book value per share, and dividends declared per share.
We continuously evaluate the credit quality of each loan by assessing the risk factors of each loan. Non-GAAP Measures and Key Financial Measures and Indicators As a commercial mortgage real estate investment trust, we believe the key financial measures and indicators for our business are Distributable Earnings, book value per share, and dividends declared per share.
Additionally, we had cash inflows related to draw downs on our Revolving Loan of $82.0 million, which were offset by $74.0 million in repayments on our Revolving Loan, approximately $39.1 million in dividends paid, approximately $0.1 million in debt issuance costs paid, and approximately $0.3 million in offering costs paid associated with the registered direct offering and ATM offering.
Additionally, we had cash inflows related to draw downs on our Revolving Loan of $142.1 million, which was offset by approximately $148 million in repayments on our Revolving Loan, approximately $43.8 million in dividends paid, approximately $0.1 million in debt issuance costs paid, and approximately $0.2 million in offering costs paid associated with the ATM offering.
Net Cash Used in Investing Activities For the years ended December 31, 2024 and 2023, we reported “Net cash used in investing activities” of $39.3 million and $1.9 million, respectively.
Net Cash Provided/(Used in) by Investing Activities For the years ended December 31, 2025 and 2024, we reported “Net cash provided by/(used in) investing activities” of approximately $8.7 million and $(39.3) million, respectively.
For the year ended December 31, 2023, cash inflows of approximately $7.2 million related to proceeds received from sales of our common stock through the registered direct offering and ATM offering of $6.0 million and $1.2 million, respectively.
For the year ended December 31, 2024, cash inflows of approximately $39.6 million related to proceeds received from sales of our common stock through the ATM offering.
Factors that could cause or contribute to those differences include, but are not limited to, those discussed above in “Risk Factors” and those identified below and elsewhere in this annual report on Form 10-K. See “Forward-Looking Statements.” Overview We are a commercial mortgage real estate investment trust.
Factors that could cause or contribute to those differences include, but are not limited to, those discussed above in “Risk Factors” and those identified below and elsewhere in this annual report on Form 10-K.
Risk Ratings We assess the risk factors of each loan, and assign a risk rating based on a variety of factors, including, without limitation, payment history, real estate collateral coverage, property type, geographic and local market dynamics, financial performance, enterprise value of the portfolio company, loan structure and exit strategy, and project sponsorship. This review is performed quarterly.
The Manager's investment committee, with input from the portfolio management team, assesses the risk factors of each loan, and assigns a risk rating based on a variety of factors, including, without limitation, payment history, real estate collateral coverage, property type, geographic and local market dynamics, financial performance, enterprise value of the portfolio company, loan structure and exit strategy, and project sponsorship.
The following table provides a reconciliation of GAAP net income to Distributable Earnings (in thousands, except per share data): Year ended Year ended December 31, 2024 December 31, 2023 Net Income $ 37,045,403 $ 38,710,248 Adjustments to net income Stock based compensation 3,058,674 1,479,736 Amortization of debt issuance costs 256,998 550,906 (Benefit) provision for current expected credit losses (583,298 ) 940,385 Change in unrealized loss (gain) on investments 240,604 (75,604 ) Distributable Earnings $ 40,018,381 $ 41,605,671 Basic weighted average shares of common stock outstanding (in shares) 19,279,501 18,085,088 Basic Distributable Earnings per Weighted Average Share $ 2.08 $ 2.30 Diluted weighted average shares of common stock outstanding (in shares) 19,713,916 18,343,725 Diluted Distributable Earnings per Weighted Average Share $ 2.03 $ 2.27 Book Value Per Share The book value per share of our common stock as of December 31, 2024 and 2023 was approximately $14.83 and $14.94, respectively.
The following table provides a reconciliation of GAAP net income to Distributable Earnings (in thousands, except per share data): 78 Year ended December 31, 2025 December 31, 2024 Net Income $ 36,010,478 $ 37,045,403 Adjustments to net income Stock based compensation 3,368,861 3,058,674 Amortization of debt issuance costs 406,663 256,998 Provision (benefit) for current expected credit losses 731,051 (583,298 ) Change in unrealized gain (loss) on investments (165,000 ) 240,604 Distributable Earnings $ 40,352,053 $ 40,018,381 Basic weighted average shares of common stock outstanding (in shares) 21,003,635 19,279,501 Basic Distributable Earnings per Weighted Average Share $ 1.92 $ 2.08 Diluted weighted average shares of common stock outstanding (in shares) 21,431,650 19,713,916 Diluted Distributable Earnings per Weighted Average Share $ 1.88 $ 2.03 Book Value Per Share The book value per share of our common stock as of December 31, 2025 and 2024 was approximately $14.60 and $14.83, respectively.
For the year ended December 31, 2023, cash outflows primarily related to $92.2 million used for the origination and funding of loans held for investment, partially offset by $13.4 million of cash received from the sale of loans and $76.9 million of cash received from the principal repayment of loans held for investment.
For the year ended December 31, 2025, cash outflows primarily related to $76.0 million used for the origination and funding of loans held for investment, offset by $84.7 million of cash received from the principal repayment of loans held for investment and loans at fair value.
Cash Flows The following table sets forth changes in cash and cash equivalents for the years ended December 31, 2024 and 2023, respectively: For the year ended December 31, 2024 2023 Net income $ 37,045,403 $ 38,710,248 Adjustments to reconcile net income to net cash used in operating activities and changes in operating assets and liabilities (13,886,027 ) (10,293,789 ) Net cash provided by operating activities 23,159,376 28,416,459 Net cash used in investing activities (39,296,863 ) (1,925,416 ) Net cash provided by/(used in) financing activities 34,639,895 (24,308,830 ) Change in cash and cash equivalents 18,502,408 2,182,213 Net Cash Provided by Operating Activities For the years ended December 31, 2024 and 2023, we reported “Net cash provided by operating activities” of approximately $23.2 million and $28.4 million, respectively.
Cash Flows The following table sets forth changes in cash and cash equivalents for the years ended December 31, 2025 and 2024, respectively: For the year ended December 31, 2025 2024 Net income $ 36,010,478 $ 37,045,403 Adjustments to reconcile net income to net cash used in operating activities and changes in operating assets and liabilities (7,217,870 ) (13,886,027 ) Net cash provided by operating activities 28,792,608 23,159,376 Net cash provided by/(used in) investing activities 8,736,720 (39,296,863 ) Net cash (used in)/provided by financing activities (48,980,892 ) 34,639,895 Change in cash and cash equivalents (11,451,564 ) 18,502,408 Net Cash Provided by Operating Activities For the years ended December 31, 2025 and 2024, we reported “Net cash provided by operating activities” of approximately $28.8 million and $23.2 million, respectively.
Net cash provided by operating activities decreased approximately $5.3 million, primarily attributable to a decrease in net income over the comparable period of approximately $1.7 million, a decrease in current expected credit losses of approximately $0.6 million, a decrease in interest receivable of approximately $0.5 million, a decrease in related party receivables of $3.3 million, a decrease in related party payables of 0.7 million, a decrease in redemption of debt securities of $1.6 million and a decrease in management and incentive fees payable of approximately $0.4 million.
Net cash provided by operating activities in 2025 increased approximately $5.6 million compared to 2024, primarily attributable to a decrease in related party receivables of approximately $5.4 million, a decrease in PIK interest of approximately $3.0 million, a decrease in the interest reserve of approximately $2.7 million, an increase in current expected credit losses of approximately $1.3 million, an increase in interest received through net settlement transactions of $1.4 million, an increase in management and incentive fees payable by $0.6 million, and an increase in stock based compensation of $0.3 million, These changes were offset by a decrease in net income over the comparable period of approximately $1.0 million, a decrease in interest receivable of approximately $2.1 million, a decrease in redemption of debt securities of $0.8 million, a decrease in accounts payable and accrued expenses of $0.8 million, a decrease in other receivables and assets by $0.7 million, and a decrease in related party payables of $0.1 million over the comparable period.
Credit Facilities Revolvin g Loan As of December 31, 2024, the Company's secured revolving credit facility (the “Revolving Loan”) has aggregate commitments of $110.0 million which may be increased to $150.0 million pursuant to its accordion feature.
As a result, we expect we will need to raise additional equity and/or debt funds to increase our liquidity in the near future. Credit Facilities Revolvin g Loan As of December 31, 2025, the Company's secured revolving credit facility (the “Revolving Loan”) has aggregate commitments of $110.0 million which may be increased to $150.0 million pursuant to its accordion feature.
We do not own any stock, warrants to purchase stock or other forms of equity in any of our portfolio companies that are involved in the cannabis industry, and we will not take stock, warrants or equity in such issuers until permitted by applicable laws and regulations, including U.S. federal laws and regulations.
We will not own any warrants or other forms of equity in any of our portfolio companies involved in the cannabis industry, unless the portfolio companies are listed on a national securities exchange, such as the New York Stock Exchange ("NYSE") or NASDAQ, and such ownership is permitted by applicable U.S. federal laws and regulations, including those applicable to NYSE or NASDAQ issuers, as the case may be.
The decrease in interest income is partially driven by the decrease in the Prime rate of 100 basis points during the year from 8.50% to 7.50%, which impacted the approximately 62.1% of the Company’s aggregate loan portfolio, which bears a floating rate as of December 31, 2024.
These increases were offset by the decrease in the Prime rate of 75 basis points during the year from 7.50% to 6.75%, which impacted approximately 62.4% of the Company’s aggregate loan portfolio, which bore a floating rate as of December 31, 2025.
As of December 31, 2024, the Company is in compliance with all financial covenants with respect to the Unsecured Notes. Capital Markets We may seek to raise further equity capital and issue debt securities in order to fund our future investments in loans.
Capital Markets We may seek to raise further equity capital and issue debt securities in order to fund our future investments in loans.
These loans are generally held for investment and are substantially secured by real estate, equipment, licenses and other assets of the borrowers to the extent permitted by the applicable laws and the regulations governing such borrowers. 63 We generate revenue primarily in the form of interest income on loans.
Our loans are generally classified as held for investment and carried at amortized cost on the consolidated balance sheets. Such loans are generally secured by real estate, equipment, licenses, intellectual property and other assets of the borrowers to the extent permitted by the applicable laws and the regulations governing such borrowers.
The impact of the declining yield was offset by the increase in outstanding principal balance of our portfolio which increased to $410.2 million as of December 31, 2024 from $355.7 million as of December 31, 2023. • Interest expense increased by approximately $1.4 million during the comparative period.
The increase in interest income was partially driven by the increase in outstanding principal balance of our portfolio, which increased to $411.1 million as of December 31, 2025 from $404.7 million as of December 31, 2024.
As of December 31, 2024 Total Principal Original Issue Discount Carrying Value Percentage of loans held for investment Fixed-rate loans $ 149,771,871 $ (545,081 ) $ 149,226,790 37.0 % Floating-rate loans 254,949,683 (1,699,427 ) 253,250,256 63.0 % Total $ 404,721,554 $ (2,244,508 ) $ 402,477,046 100.0 % As of December 31, 2024, the Company has one loan held at fair value with a principal balance of $5.5 million, which bears a fixed rate.
As of December 31, 2025 Total Principal Original Issue Discount Carrying Value Percentage of loans held for investment Fixed-rate loans $ 154,680,286 $ (803,019 ) $ 153,877,267 37.6 % Floating-rate loans 256,394,802 (1,316,502 ) 255,078,300 62.4 % Total $ 411,075,088 $ (2,119,521 ) $ 408,955,567 100.0 % As of December 31, 2024 Total Principal Original Issue Discount Carrying Value Percentage of loans held for investment Fixed-rate loans $ 149,771,871 $ (545,081 ) $ 149,226,790 37.1 % Floating-rate loans 254,949,683 (1,699,427 ) 253,250,256 62.9 % Total $ 404,721,554 $ (2,244,508 ) $ 402,477,046 100.0 % As of December 31, 2025, none of our loans were held at fair value.
Expenses Our primary operating expense is the payment of Base Management Fees and Incentive Compensation under our Management Agreement with our Manager and the allocable portion of overhead and other expenses paid or incurred on our behalf, including reimbursing our Manager for a certain portion of the compensation of certain personnel of our Manager who assist in the management of our affairs, excepting only those expenses that are specifically the responsibility of our Manager pursuant to our Management Agreement.
Year ended December 31, 2025 Interest income Percentage of loans held for investment Fixed-rate loans $ 23,605,873 37.6 % Floating-rate loans 39,330,167 62.4 % Total $ 62,936,040 100.0 % Year ended December 31, 2024 Interest income Percentage of loans held for investment Fixed-rate loans $ 23,506,855 37.9 % Floating-rate loans 38,597,237 62.1 % Total $ 62,104,092 100.0 % Expenses Our primary operating expenses are the payment of Base Management Fees and Incentive Compensation under our Management Agreement with our Manager and the allocable portion of overhead and other expenses paid or incurred on our behalf, including reimbursing our Manager for a certain portion of the compensation of certain personnel of our Manager who assist in the management of our affairs, excepting only those expenses that are specifically the responsibility of our Manager pursuant to our Management Agreement.
In July 2024, we entered into an amendment to Loan #3, which extended the maturity date to January 29, 2027 of two of the three tranches held. No other terms of the loan were modified in connection with this amendment.
Following the issuance of the Default Notice, Management began the process to exercise its rights and remedies under the loan documents. In June 2025, we entered into an amendment to Loan #16, which extended the maturity date to January 29, 2027. No other terms of the loan were modified in connection with this amendment.
The weighted average price for sales of our common stock in connection with the ATM program was $15.90 for the year ended December 31, 2024 and $15.78 for the year ended December 31, 2023. 76 As of December 31, 2024, the shares of common stock sold pursuant to the registered direct offering in February 2023 and under the ATM Program are the only offerings that have been initiated under the Shelf Registration Statement.
As of December 31, 2025, the shares of common stock sold pursuant to the registered direct offering in February 2023 and under the ATM Program are the only offerings that have been initiated under the Shelf Registration Statement. We may seek to raise further equity capital and issue debt securities in order to fund our future investments in loans.
Market Conditions We believe that favorable market conditions, including an imbalance in supply and demand of credit to cannabis operating companies, have provided attractive opportunities for non-bank lenders, such as us, to finance commercial real estate loans and other loans that exhibit strong fundamentals but also require more customized financing structures and loan products than regulated financial institutions can presently provide.
We believe that cannabis operators’ limited access to traditional bank and non-bank financing has provided attractive opportunities for us to make loans to companies that exhibit strong fundamentals but require more customized financing structures and loan products than regulated financial institutions can provide in the current regulatory environment.
Management fees increased by approximately $0.1 million, resulting from the increase in weighted average equity which increased to approximately $302.4 million from $283.5 million as of December 31, 2024 and 2023, respectively.
Management fees increased by approximately $0.3 million, resulting from the increase in Equity, as defined in the Management Agreement. Total stockholders' equity was $307.8 million and $309.0 million as of December 31, 2025 and 2024, respectively.
Additionally, the weighted average YTM IRR on our portfolio decreased from 19.4% to 17.2% during the year, as a result of certain re-pricing amendments relating to de-risking of our portfolio and the impact of the 100 basis point prime rate decline on our floating rate portfolio.
Additionally, the weighted average YTM IRR on our portfolio decreased from 17.2% to 16.3% during the year, as a result of certain re-pricing amendments relating to de-risking of our portfolio and new 2025 loan originations having a lower YTM IRR than the weighted average at December 31, 2024. • Interest expense increased by approximately $0.4 million during the comparative period.
Recent Developments Updates to Our Credit Facilities during Fiscal Year 2024 Revolving Loan On February 28, 2024, CAL entered into a Fifth Amended and Restated Loan and Security Agreement (the “Fifth Amendment and Restatement”).
Updates to Our Credit Facilities during Fiscal Year 2025 Revolving Loan On August 5, 2025, CAL entered into the First Amendment to the Sixth Amended and Restated Loan and Security Agreement (the "August 2025 Amendment"). The August 2025 Amendment extended the contractual maturity date from June 30, 2026 to June 30, 2028.
No other terms of the loan were modified in connection with this amendment. In June 2024, we entered into an amendment to Loan #4, which extended the maturity date from May 17, 2024 to June 17, 2026, and decreased the PIK rate from 15% to 0%.
No other terms of the loan were modified in connection with this amendment. 74 In December 2025, Loan #2 was amended, which extended the maturity date from December 31, 2025 to December 31, 2026.
Overhead expense reimbursements for costs incurred by the Manager, which are reflected in the General and administrative expense on the consolidated statement of operations, remained flat at $4.8 million for the year ended December 31, 2024 and 2023. 70 • Stock based compensation increased by approximately $1.6 million as a result of a full year of expense recognition on the grant of 323,452 restricted stock awards granted to employees of our Manager during the year ended December 31, 2023, as well as an additional 187,335 of restricted stock awards granted during the year ended December 31, 2024.
There were no significant or unusual direct or reimbursable expense changes during the year. • Stock based compensation increased by approximately $0.3 million as a result of a full year of expense recognition on the grant of 187,335 restricted stock awards granted to employees of our Manager during the year ended December 31, 2024, as well as an additional 187,157 of restricted stock awards granted during the year ended December 31, 2025.
The Notes Payable, which were not included in interest expense during the year ended December 31, 2023, contributed to approximately $1.0 million of the increase. Additionally, the weighted average borrowings under our Revolving Loan increased to $67.0 million from $60.6 million during the years ended December 31, 2024 and 2023, respectively.
This increase was offset by a decrease in interest expense on our Revolving Loan driven by a decrease in the weighted average borrowings from $67.0 million to $32.8 million during the years ended December 31, 2025 and 2024, respectively.
Additionally, we received approximately $1.8 million of scheduled principal repayments. 69 Results of Operations Comparison of the years ended December 31, 2024 and 2023 For the year ended December 31, Variance 2024 2023 Amount % Revenues Interest income $ 62,104,092 $ 62,900,004 $ (795,912 ) -1 % Interest expense (7,153,207 ) (5,752,908 ) (1,400,299 ) 24 % Net interest income 54,950,885 57,147,096 (2,196,211 ) -4 % Expenses Management and incentive fees, net 8,061,896 8,782,834 (720,938 ) -8 % General and administrative expense 5,388,967 5,260,287 128,680 2 % Professional fees 1,811,067 2,153,999 (342,932 ) -16 % Stock based compensation 3,058,674 1,479,736 1,578,938 107 % (Benefit) provision for current expected credit losses (583,298 ) 940,385 (1,523,683 ) -162 % Total expenses 17,737,306 18,617,241 (879,935 ) -5 % Change in unrealized (loss) gain on investments (240,604 ) 75,604 (316,208 ) 100 % Realized gain on debt securities, at fair value 72,428 104,789 (32,361 ) 100 % Net Income before income taxes 37,045,403 38,710,248 (1,664,845 ) -4 % Income tax expense - - - - Net Income $ 37,045,403 $ 38,710,248 $ (1,664,845 ) -4 % • Gross interest income decreased by approximately $0.8 million for the year ended December 31, 2024 compared to the year ended December 31, 2023.
Results of Operations for the years ended December 31, 2025 and 2024 For the year ended December 31, Variance 2025 2024 Amount % Revenues Interest income $ 62,936,040 $ 62,104,092 $ 831,948 1 % Interest expense (7,545,641 ) (7,153,207 ) (392,434 ) 5 % Net interest income 55,390,399 54,950,885 439,514 1 % Expenses Management and incentive fees, net 8,202,136 8,061,896 140,240 2 % General and administrative expense 5,304,451 5,388,967 (84,516 ) -2 % Professional fees 1,938,422 1,811,067 127,355 7 % Stock based compensation 3,368,861 3,058,674 310,187 10 % Provision (benefit) for current expected credit losses 731,051 (583,298 ) 1,314,349 -225 % Total expenses 19,544,921 17,737,306 1,807,615 10 % Change in unrealized gain (loss) on investments 165,000 (240,604 ) 405,604 NM Realized gain on debt securities, at fair value - 72,428 (72,428 ) 100 % Net Income before income taxes 36,010,478 37,045,403 (1,034,925 ) -3 % Income tax expense - - - - Net Income $ 36,010,478 $ 37,045,403 $ (1,034,925 ) -3 % 76 • Gross interest income increased by approximately $0.8 million for the year ended December 31, 2025, compared to the year ended December 31, 2024.
The increase in weighted average borrowings was offset by the decrease in the Revolving Loan interest rate, which is based off of the Prime Rate that decreased 100 basis points during 2024.
The increase in interest expense on our Notes Payable was also partially offset by the decrease in the Revolving Loan interest rate, which is based off of the Prime Rate that decreased 75 basis points during 2025. • Management and incentive fees increased approximately $0.1 million during the comparative periods ending December 31, 2025 and 2024.
In October 2024, we originated Loan #36, a $27.0 million term loan to an operator in Illinois, of which $25.0 million was funded at closing. The loan bears interest at a floating rate, based on the prime rate, and a spread of 6.25% subject to a 7.50% prime rate floor.
On December 31, 2025, we originated Loan #44, a $5.0 million term loan to a cannabis operator with primary operations in Missouri, of which $4.9 million was funded at closing. The loan bears interest at a floating rate, based on SOFR, and a spread of 10.24%, subject to a 3.72% SOFR floor. The loan is interest-only through the maturity date.
The Company sold shares of common stock directly, without the use of underwriters or placement agents, to institutional investors registered pursuant to its effective shelf registration statement. At-the-Market Offering Program (“ATM” Program”) On June 20, 2023, the Company entered into an At-the-Market Sales Agreement (the “Sales Agreement”) with BTIG, LLC, Compass Point Research & Trading, LLC and Oppenheimer & Co.
At-the-Market Offering Program (“ATM” Program”) On June 20, 2023, the Company entered into separate At-the-Market Sales Agreement (each, a "Sales Agreement" and together, the “Previous Sales Agreements”) with BTIG, LLC, Compass Point Research & Trading, LLC and Oppenheimer & Co. Inc.
Certain of our loans have extension fees, which are not included in our YTM IRR calculations, but may increase YTM IRR if such extension options are exercised by borrowers. The below table summarizes our portfolio of loans held for investment by rate type as of December 31, 2024 and 2023.
Certain of our loans have extension or amendment fees, which are not included in our YTM IRR calculations, but may increase YTM IRR if such extension options are exercised by borrowers. Our loans bear interest rates that are either fixed or determined periodically on the basis of Prime or SOFR plus a premium.
No other material terms were modified as a result of the execution of this amendment. Notes Payable On October 18, 2024, the Company entered into a Loan Agreement by and among the Company and the various financial institutions party thereto, for an aggregate commitment of $50.0 million in senior unsecured notes (the "Notes Payable").
No other material terms were modified as a result of the execution of this amendment, and the Company incurred approximately $0.1 million in financing costs relating thereto.
The Prime Rate during the years ended December 31, 2024 and 2023 was as follows: Effective Date Rate (1) December 19, 2024 7.50 % November 8, 2024 7.75 % September 19, 2024 8.00 % July 27, 2023 8.50 % May 4, 2023 8.25 % March 23, 2023 8.00 % February 2, 2023 7.75 % (1) Rate obtained from the Wall Street Journal’s “Bonds, Rates & Yields” table.
The below table summarizes changes in Prime and SOFR during the years ended December 31, 2025 and 2024: Prime Rate Effective Date Rate (1) December 11, 2025 6.75 % October 30, 2025 7.00 % September 18, 2025 7.25 % December 19, 2024 7.50 % November 8, 2024 7.75 % September 19, 2024 8.00 % (1) Rate obtained from the Wall Street Journal’s “Bonds, Rates & Yields” table. 67 SOFR Effective Date Rate (2) December 31, 2025 3.87 % September 30, 2025 4.45 % June 30, 2025 4.45 % March 31, 2025 4.41 % December 31, 2024 4.49 % September 30, 2024 4.96 % June 30, 2024 5.40 % March 31, 2024 5.35 % December 31, 2023 5.38 % (2) Rate obtained from the Federal Reserve Bank of New York's "Secured Overnight Financing Rate Data" table The below table summarizes the gross interest income derived from fixed and floating-rate loans during the years ended December 31, 2025 and 2024 based on portfolio composition as of the year end date.
In total, our loans held for investment, at carrying value, increased by $48.9 million, from $353.6 million at December 31, 2023 to $402.5 million as of December 31, 2024. In February 2024, we entered into an amendment to Loan #16, which modified certain financial covenants.
These increases were offset by proceeds from principal repayment of loans in the amount of $84.7 million. In total, our loans held for investment, at carrying value before CECL reserves, increased by approximately $6.5 million, from $402.5 million at December 31, 2024 to $409.0 million as of December 31, 2025.
We are an externally managed Maryland corporation that elected to be taxed as a REIT under Section 856 of the Code, commencing with our taxable year ended December 31, 2021. We believe that we have qualified as a REIT and that our method of operation will enable us to continue to qualify as a REIT.
We completed our initial public offering ("IPO") in December 2021 and have elected to be taxed as a REIT for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with our taxable year ended December 31, 2021.
No monetary terms of the loan were modified in connection with the amendment. 67 In February 2024, we entered into an amendment to Loan #6, which extended the maturity date to April 15, 2024. No other terms of the loan were modified in connection with this amendment.
On December 31, 2025, Loan #18 was amended, which extended the original maturity date from December 31, 2025 to December 31, 2026. No other terms of the loan were modified in connection with this amendment. We recognized $1.0 million of success fees that were due and payable on the original maturity date.
As of December 31, 2024 and 2023, 36.5% and 27.1%, respectively, of the loan principal held in our portfolio are backed by personal or corporate guarantees. We aim to maintain a portfolio diversified across jurisdictions and across verticals, including cultivators, processors, dispensaries, as well as ancillary businesses.
We aim to maintain a diversified portfolio across jurisdictions and verticals, including cultivators, processors, dispensaries, and other businesses ancillary thereto.
Our Investment Guidelines are not subject to any limits or proportions with respect to the mix of target investments that we make or that we may in the future acquire other than as necessary to maintain our exemption from registration under the Investment Company Act and our qualification as a REIT.
From time to time, we may also invest in mezzanine loans, preferred equity or other forms of joint venture equity to the extent consistent with our exemption from registration under the Investment Company Act of 1940, as amended (the “Investment Company Act”) and maintaining our qualification as a REIT.
In June 2024, we entered into an amendment to Loan #12, which extended the maturity date to April 30, 2025. Amortization payments began again on July 31, 2024 at $60,000 per month. No other terms of the loan were modified in connection with this amendment.
In December 2025, Loan #8 was amended, which extended the maturity date from December 31, 2025 to June 30, 2026. Further, the agreed upon interest rate increased 200 basis points to 12% as of the effective date. No other terms of the loan were modified in connections with this amendment.
Updates to Our Loan Portfolio during Fiscal Year 2024 For the year ended December 31, 2024, our cash loan fundings of loans held for investment, net of original issue discounts and other upfront fees were approximately $161.3 million. We received approximately $121.5 million of total proceeds from sales and principal amortization of loans of $19.0 million and $102.5 million, respectively.
Recent Developments Updates to Our Loan Portfolio during Fiscal Year 2025 For the year ended December 31, 2025, we advanced gross principal of $79.4 million, which resulted in cash advances of $77.3 million, net of upfront fees, including original issue discount of $2.1 million. Further, we capitalized $6.2 million of PIK interest during the year.